IP Verse

Silence Therapeutics Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Silence Therapeutics Gmbh

Patent Number:
EP2813582
Title:
Rna Interference Mediating Small Rna Molecules
Applicant:
EUROPÄISCHES LABORATORIUM FÜR MOLEKULARBIOLOGIE (EMBL)
Opposition Date:
Jan 12, 2018
Patent Number:
EP1798285
Title:
Methods And Medicament For Inhibition The Expression Of A Defined Gene
Applicant:
ALNYLAM EUROPE AG
Opposition Date:
Dec 15, 2017

Latest patents of Silence Therapeutics Gmbh opposed by its competitors

Patent:
EP3607069
Grant Date:
Nov 2, 2022
Title:
Products And Compositions
Oppositions:
1
Patent:
EP1857547
Grant Date:
Dec 2, 2020
Title:
Further Novel Forms Of Interfering Rna Molecules
Oppositions:
3
Patent:
EP2258847
Grant Date:
Jul 1, 2020
Title:
Futher Novel Forms Of Interfering Rna Molecules
Oppositions:
3
Patent:
EP3222724
Grant Date:
Oct 31, 2018
Title:
Further Novel Forms Of Interfering Rna Molecules
Oppositions:
1

Competitors of Silence Therapeutics Gmbh

ALNYLAM PHARMACEUTICALS INC.

SANOFI

THE MEDICINES COMPANY UK LIMITED

Want to track Silence Therapeutics Gmbh?

Feel free to send us a message here and we will get back to you